CONSTELLIUM SE 8-K

What Happened

• Constellium SE filed an 8-K on May 21, 2026 reporting results from its Annual General Meeting. Shareholders ratified the interim appointment and approved the three‑year appointment of Ingrid Joerg and re‑appointed John Ormerod to the board for three years. Shareholders also voted, on an advisory (non‑binding) basis, to hold the company’s executive compensation (“say‑on‑pay”) vote every year; the company has adopted an annual advisory vote going forward.

Key Details

• Ingrid Joerg: ratification voted For 97,942,587; appointment for a three‑year term voted For 97,919,555 (against 343,694; abstained 80,607; broker non‑votes 10,462,884).
• John Ormerod: re‑appointment for a three‑year term voted For 82,318,163 (against 15,907,876; abstained 117,817; broker non‑votes 10,462,884).
• Say‑on‑pay frequency: annual option voted For 98,273,291 (against 31,220; abstained 39,345; broker non‑votes 10,462,884); the company will hold advisory votes on named executive officer pay every year.
• Financial and capital authorizations: statutory and consolidated 2025 financial statements approved (statutory For 107,959,981; consolidated For 107,958,765); shareholders approved share repurchase authorization (For 108,617,538) and two authorizations to cancel repurchased shares/carry out capital reductions (For 108,728,505 and For 108,724,554). Note: under French law broker non‑votes are treated as abstentions and were not counted as votes cast.

Why It Matters

• Governance: The board composition is confirmed (Joerg added; Ormerod re‑appointed) and the board now faces an annual, non‑binding shareholder review of executive pay—an outcome investors often watch as a signal of governance responsiveness.
• Capital policy: Approval of share buyback and cancellation authorizations gives the board flexibility to repurchase and cancel shares, which can affect share count and per‑share metrics if executed.
• Financial sign‑offs: Shareholder approval of the 2025 statutory and consolidated financial statements and discharge of management completes key governance steps for last fiscal year.
• Voting dynamics: Several items drew notable opposition or abstentions (for example ~15.9M votes against Ormerod’s re‑appointment and ~12.7M abstentions on the advisory approval of 2025 executive compensation), indicating some shareholder dissent on specific matters.

Filing note: The Form 8‑K was signed by CFO Jack Guo and filed May 21, 2026.